• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

2026 AGM Information

Notice of Annual General Meeting

This is a notice regarding the International Alliance of ALS/MND Associations’ Annual General Meeting (AGM), taking place virtually via Zoom.

Date: Tuesday, November 24, 2026
Time: 9:00–10:00 am EST 
Zoom link: To be confirmed

We value our members’ input. If you’d like to submit an agenda item, please use the links below to fill out a form.

  • Call for Agenda Items (member login required)
  • Call for Resolutions (member login required)

The deadline to submit agenda items and resolutions is October 8, 2026.

Thank you to our members who submitted a nomination for the Board of Directors. Nominations are now closed. Electronic voting will be sent to Alliance delegates who are eligible for voting shortly.

The AGM agenda along with the Annual Report and Financial Statements will be distributed before the meeting. 

Voting

Voting will be conducted by a show of hands from virtual participants at the meeting. 

The items under vote will be shared before the meeting.

Questions

The Alliance welcomes your questions in advance of the AGM. Please send them to cathy.cummings@als-mnd.org. You will also have the opportunity to ask questions during the AGM. 

Proxy Vote Instructions & Form

  1. As a member of the Charity, you are entitled to appoint a proxy to exercise all or any of your rights to attend, speak, and vote at the meeting.
  2. You can only appoint a proxy using the procedures set out in these notes.
  3. A proxy must be an authorized representative of the member (no other individuals are permitted to be proxies) and must attend the meeting to represent you.
  4. If no voting indication is given, your proxy will vote or abstain from voting on the resolutions put to the meeting at their discretion.
  5. Unless the proxy appointment indicates otherwise, it will be treated as:
    • allowing your proxy to vote (or abstain from voting) as they see fit in relation to the limited range of additional resolutions which may be put before the meeting; and
    • appointing your proxy in relation to any adjournment of the meeting.
  6. Proxy appointments must be made using the form below or in writing and emailed to the Secretary of the Charity, Catherine Cummings, at cathy.cummings@als-mnd.org.
  7. The proxy appointments must be notified to the Secretary of the Charity before the commencement of the meeting.
  8. If you are completing the proxy appointment under the authority of a power of attorney or any other authority, you must send the relevant document or a certified copy to the Secretary of the Charity when you return the proxy appointment.
  9. If you wish to change your proxy instructions, you may submit another appointment in the way indicated above. The appointment received last before the latest time for the receipt of proxies will take precedence.
  10. If you wish to revoke your proxy instructions, you may send a notice to the Secretary of the Charity in any of the ways described at note 6 above clearly stating that the instructions are revoked. The revocation must be received by the Secretary of the Charity no later than the commencement of the meeting.
  11. Appointment of a proxy does not preclude you from attending the meeting and voting yourself. If you have appointed a proxy and you attend the meeting and cast a vote yourself, your proxy is no longer entitled to vote on your behalf.
  12. You may only communicate with the Charity about the meeting and appointing a proxy for the meeting using the addresses at note 6. No other methods of communication will be accepted.

2026 Proxy Form

As a member of the Charity, you are entitled to appoint a proxy through this form to exercise all or any of your rights to attend, speak and vote at the meeting.

This field is hidden when viewing the form

2026 Proxy Form

It is the responsibility of the member to determine whether the person to whom they assign the proxy is able and agrees to act in the manner described. Please ensure submission of the completed proxy to the International Alliance of ALS/MND Associations no later than November 17, 2026, at 5:00 pm ET.
Your Name(Required)
I, a voting member in good standing of the International Alliance of ALS/MND Associations, hereby appoint the following person as my proxy to attend, act, and vote on my behalf at the Annual General Meeting of members to be held virtually on November 24, 2026, at 9:00 am ET (including adjournments thereof).(Required)
Failing the person named above, I hereby give my proxy to the following person.(Required)
OR (complete only if you wish to name someone other than the above as your proxy) I hereby appoint the following person, a voting member in good standing, as my proxy to attend, act, and vote on my behalf at the Annual General Meeting of members to be held virtually on November 24, 2026, at 9:00 am ET (including adjournments thereof).
By completing the following boxes, the signing party listed below digitally confirms the proxy appointment.

Primary Sidebar

  • Rob Tison, USA

    Rob Tison, USA

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Alex, Argentina

    Alex, Argentina

  • Purningam Jacob, India

    Purningam Jacob, India

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Lombana, Spain

    Lombana, Spain

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Susan Keldani, USA

    Susan Keldani, USA

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Mike Small, UK

    Mike Small, UK

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Greg Heydet, USA

    Greg Heydet, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • Jay Epstein, USA

    Jay Epstein, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Bob Simonds, USA

    Bob Simonds, USA

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Daniel Hare, USA

    Daniel Hare, USA

  • Bayley, Australia

    Bayley, Australia

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Dick Dayton, USA

    Dick Dayton, USA

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login